Potentiating Andrographolide’s Antineoplastic Characters for Evading Malignant Transformation of Stem Cells
- 1. Department of Biological Sciences, Indian Institute of Science Education and Research, India
ABSTRACT
Stem cells are differentially modulated and fated by the influence of their microenvironment, commonly known as ‘stem cell niche’. Studies of stem cell niche transformation leading to its malignancy and signaling molecules involved therein, is greatly limited by the fading boundaries of distinction between the existing cancerous cells and the de-novo transformed cells of the stem cell niche. The potent question being addressed in this communication focuses on developing new strategies to limit the malignant transformation of stem cells using andrographolide (a plant derived compound), which has been extensively used in Indian and Chinese traditional medicine. In this study we try to extend the inhibiting effect of andrographolide on Interleukin-6 (IL-6) expression (both mRNA and protein) leading to the onset of a wide range of anti-cancerous and chemo-protective biological functions.
KEYWORDS
Andrographolide;Interleukin-6 (IL-6);Reactive oxygen species (ROS);Apoptosis, Angiogenesis;Cell cycle; Immunomodulation; Stem cell niche.
CITATION
Satapathy S (2014) Potentiating Andrographolide’s Antineoplastic Characters for Evading Malignant Transformation of Stem Cells. J Cancer Biol Res 2(2): 1050.
INTRODUCTION
The stem cell niche has critical importance in deciding the stemmness and proliferative potential of the cells as well as determining the induction of differentiation to attain a fate [1- 12]. However in context of growing evidences of malignancy in cells due to external carcinogenic factors like toxic radiations (e.g. UV); heavy metals (e.g. arsenic, lead etc.); DNA damage etc. [2,3,6]. Several external factors leading to carcinogenesis are known to induce the expression of oncogenes or activation of proto-oncogenes either in a randomly spontaneous manner or inform of a series of accumulated mutations [1,3]. These transforming cells can be either the cells of the stem cell niche or the cells neighboring the niche, which would ultimately result in transformed niche and affect the properties of the residing stem cells. IL-6 has been as the key cytokine involved in signaling of and between such transformed cells [1,3-5]. IL-6 mediated signaling has been implicated for its dual role in both tumor progression and suppression [6]. Therefore, selectively targeting the IL-6 expression is a promising strategy to evade such neoplastic transformations. Screening of large number of potential plant-derived compounds has highlighted ‘andrographolide’, as a key compound for multifaceted biological functions like anticancerous, proapoptotic, anti-angiogenic and cell cycle arrest [13,14,15,18,22]. Andrographolide (C20H30O5 ), a diterpenoid lactone derived from Andrographolide paniculata Nees has an added advantage of being extensively studied for their physio-chemical properties like structure, bond properties and stereochemistry [10,18,20]. This compound has been extensively used in herbal medicines of India and China for the liver disorder, cardiovascular problems, fever, diarrohea and herpes etc [8,9,13] (Figure 1).
Figure 1 Structure of Andrographolide.
Apart from andrographolide, several other natural products that can be competitive natural analogues are under clinical trials [15,17,21]. The chemical analogues of andrographolide that have identified by Jada et al. are 3,19-isopropylideneandrographolide;14-acetyl-3,19- isopropylideneandrographolide;14-acetylandr- ographolide; 3,19-(2-bromobenzylidene) andrographolide and 3,19-(3-chloro4-fluorobenzylidene)and- rographolide [ 27].
PROSPECTIVE METHOD
The proposed strategy utilizes the drug, andrographolide in preventing normal stem cell carcinogenesis. Arsenic transformed malignant cells are known to be potential xenobiotic source for inducing cancer due to events like active mutagenesis following heavy metal contamination. Arsenic transformed malignant cells are shown to have a role in converting normal stem cells into cancer stem cells, when cultured non contiguously. This contact is conducted by the release of IL-6 during contiguous cell culture. The mechanism of secretion of the interleukin-6 by the MECs even though is not completely understood. In this study we would like to check whether andrographolide, an interleukin-6 inhibitor could prevent or limit the potency of arsenic induced MECs to convert normal stem cells to cancerous stem cells when arsenic transformed malignant cells pretreated with the drug are co-cultured non contiguously with normal stem cells as well as treating the co-culture with andrographolide without any pretreatment when co-cultured non-continuously (Figure 3).
Figure 3 Effect of andrographolide on evading malignant transformation of stem cells. (a) To check the transformational ability of cancerous cell for the co-cultured stem cell. (b)To check the transformational ability of cancerous cell for the co cultured stem cell with administration of andrographolide without any pretreatment. (c) To check the transformational ability of andrographolide pretreated cancerous cell for the co cultured stem cell.
DISCUSSION
IL-6 Inhibition
IL-6, a pleotropic cytokine has specific IL-6 receptors (IL-6R), with its alpha subunit binding to IL-6 and the signal transducer unit, i.e. gp-130. Three of these subunits form a hexameric complex with two molecules of each subunit [18]. The IL-6R responds to both intrinsic constitutive and extrinsic administered IL-6 levels. In most human cancers usage of andrographolide has significantly limited the subsequent IL-6 levels both at mRNA and protein level [16]. In case of human prostrate cancer, andrographolide inhibits both autocrine and paracrine mediated IL-6 signaling and is independent of the cell type [23,24]. The level of IL-6 and its receptor expression has been consistently related to the progressing stages of cancer and is most significant at benign hyperplasia and metastasis. Furthermore with the increasing tumor mass the IL-6 levels become significantly high and thus can be targeted for anti cancerous drug designing [30,31,32]. In case of human prostrate cancer cells the binding of IL-6 to androgen receptors (AR) is signaled by Stat3, which overexpresses AR in an androgen deprivation therapy [23,25]. Stat3Tyr705 has been identified as an important signaling moiety for IL-6 signaling and is strongly limited for phosphorylation in presence of andrographolide. Along with Stat3 pathway, MAPK, Akt (Ser473) and Erk pathway induced cell proliferation is inhibited by andrographolide treatment [28,29]. Even, the v-src induced Erk1/2 phosphorylation and Akt phosphorylation is inhibited.
Synergistic cancer evasion
In addition to the IL-6 inhibition and subsequent signaling alteration, andrographolide also initiates a wide range of biological pathways that promote anticancerous hallmarks (cell cycle arrest, cytotoxicity of cancer cells) and down regulate pro-cancerous hallmarks (angiogenesis, Immunomodulation and apoptosis evasion). Apart from its effect on cancerous cells, andrographolide is also known to have a protective potential of healthy cells and also selectively eliminate the cancerous cells (Figure 2).
Figure 2 Wide-range of Cancer inhibiting actions of andrographolide up regulating the anti-cancerous hallmarks and the Protective potential and down regulating the pro-cancerous hallmarks
Also there is a significant lowering of expression of proteins like Cyclin-D, Cyclin-A, CDK-4, CDK-2 (important for progression of cell cycle into synthetic and mitotic phases) and overexpression of CDK Inhibitors (cyclin dependent kinases), cyclin inhibitors like p16, p21, p27 ultimately leading to arrest of cell cycle at G0/G1 phase [26]. In cases of lymphocytic leukemia and human epidermoid leukemia it has been known that alcoholic extract of andrographolide is effective in inducing cytotoxicity of cancerous cells.
Andrographolide is also known to increase the apoptosis and necrosis of cancerous cells [17]. Apoptosis promotion occurs in a strategic manner by up regulation of extrinsic ligands for the ligand-receptor based induction of apoptosis. There is a subsequent overexpression of both activator caspase (caspase8) and effector caspases (caspase3/7/9) along with subsequent amplication of the mitochondrial signal in form of cytochrome c via the pro-apoptotic Bcl-2 family of protein upregulation [20]. Further the TNF-alpha ligand expression is elevated in presence of andrographolide that helps in induction of apoptosis via TRAIL pathway (TNF-alpha related apoptosis inducing ligand). This plant-derived lactone is also known to reduce the levels of NF-κB and IFN-v along with the levels of ROS (reactive oxygen species)
and RNS (reactive nitrogen synthase) and thereby limiting the overall cell-proliferation ability [31,32]. IL-2 level also rises subsequent to the treatment of andrographolide that helps in cytotoxicity of cancerous cells [12,16,21]. Angiogenesis promoting factors like VEGF (Vascular epithelial Growth factor), NO (nitric oxide), VCAM (vesicular cell adhesion molecule) are lowered along with upregulation of inhibitor of metalloproteinases in presence of andrographolide [25].
Andrographolide is now a day’s being effectively used in combination therapy along with chemotherapy in order to escalate the effectiveness of chemotherapy along with elimination of undesired side effects. In case of healthy cells, andrographolide extends its friendly characteristics by protecting the cells from chemicals like cyclophosphamide, hydrocortisone, hepatotoxins etc. [23].
CONCLUSION
It had been shown that andrographolide plays an important role in the inhibition of Janus tyrosine kinasessignal transduction pathways, Phosphatidylinositol 3-kinase (PI-3K) and NF-κB signaling pathways and the induction of tumour suppressor proteins p53 and p21. All theses leading to inhibition of cancer cell proliferation, survival, metastasis and angiogenesis. So understanding the effect of andrographolide will play an important role in developing novel drugs against cancer treatment and stem cell homeostasis. In future days the major question to address for andrographolide research will be to translate the invitro experiments into animal models and to understand their biological significance.